Financial Gravity Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $1.79M | Buy |
+25,730
| New | +$1.79M | 0.39% | 64 |
|
2024
Q2 | $3.34M | Sell |
23,382
-23,304
| -50% | -$3.33M | 0.83% | 28 |
|
2024
Q1 | $5.41M | Sell |
46,686
-231,821
| -83% | -$26.9M | 0.73% | 32 |
|
2023
Q4 | $148M | Buy |
278,507
+23,511
| +9% | +$12.5M | 1.57% | 12 |
|
2023
Q3 | $146M | Buy |
254,996
+237,672
| +1,372% | +$136M | 1.61% | 11 |
|
2023
Q2 | $2.2K | Sell |
17,324
-522
| -3% | -$66 | 0.01% | 622 |
|
2023
Q1 | $5.75K | Buy |
17,846
+12,006
| +206% | +$3.87K | 0.18% | 132 |
|
2022
Q4 | $1.32K | Sell |
5,840
-768
| -12% | -$174 | 0.01% | 612 |
|
2022
Q3 | $285 | Sell |
6,608
-11,550
| -64% | -$498 | 0.01% | 485 |
|
2022
Q2 | $935 | Buy |
18,158
+10,854
| +149% | +$559 | 0.03% | 322 |
|
2022
Q1 | $339 | Sell |
7,304
-8,208
| -53% | -$381 | 0.01% | 484 |
|
2021
Q4 | $680 | Buy |
15,512
+2,140
| +16% | +$94 | 0.02% | 439 |
|
2021
Q3 | $731K | Sell |
13,372
-16,752
| -56% | -$916K | 0.34% | 54 |
|
2021
Q2 | $1.35M | Buy |
30,124
+2,834
| +10% | +$127K | 0.48% | 47 |
|
2021
Q1 | $935 | Buy |
27,290
+12,026
| +79% | +$412 | 0.02% | 306 |
|
2020
Q4 | $532K | Buy |
+15,264
| New | +$532K | 0.49% | 60 |
|
2020
Q2 | – | Sell |
-3,972
| Closed | -$8.93K | – | 604 |
|
2020
Q1 | $8.93K | Buy |
3,972
+3,764
| +1,810% | +$8.46K | 0.03% | 233 |
|
2019
Q4 | $58K | Buy |
208
+32
| +18% | +$8.92K | 0.04% | 562 |
|
2019
Q3 | $5K | Sell |
176
-48
| -21% | -$1.36K | ﹤0.01% | 703 |
|
2019
Q2 | $6K | Sell |
224
-170
| -43% | -$4.55K | ﹤0.01% | 663 |
|
2019
Q1 | $10K | Buy |
+394
| New | +$10K | 0.01% | 556 |
|
2018
Q3 | $4K | Sell |
208
-14
| -6% | -$269 | ﹤0.01% | 788 |
|
2018
Q2 | $5K | Sell |
222
-16
| -7% | -$360 | ﹤0.01% | 765 |
|
2018
Q1 | $6K | Buy |
+238
| New | +$6K | 0.01% | 682 |
|